Stay updated with breaking news from Xiling Shen. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Xilis Announces Formation of its Scientific Advisory Board Company developing breakthrough clinically-predictive patient tumor avatar platform with native tumor–immune biology to accelerate drug discovery and development andrevolutionize patient care DURHAM, N.C. – December 15, 2022 – Xil...
The Terasaki Institute for Biomedical Innovation (TIBI) will be hosting the Terasaki Innovation Summit on March 8-10, 2023, at the UCLA Meyer & Renee Luskin Center in Los Angeles.
Press release content from Business Wire. The AP news staff was not involved in its creation.
-- Proceeds will enable Xilis to build its capabilities in supporting biopharma collaborations for drug discovery -- -- Extension led by new investor FPV Ventures -- Xilis, Inc., a pioneering biotechnology
The firm will use the money to advance its tumor organoid platform, which can be used for precision oncology drug discovery and for guiding treatment decisions.